Grantham, Mayo, Van Otterloo & Co (GMO)’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,383	Closed	-$157K	–	975
2020 Q4	$157K	Sell	2,383 -6,311	-73%	-$411K	﹤0.01%	788
2020 Q3	$472K	Sell	8,694 -90	-1%	-$6.88K	﹤0.01%	630
2020 Q2	$838K	Buy	8,784 +4,804	+121%	+$358K	0.01%	559
2020 Q1	$204K	Sell	3,980 -3,025	-43%	-$316K	﹤0.01%	702
2019 Q4	$576K	Hold	7,005	–	–	﹤0.01%	579
2019 Q3	$599K	Buy	7,005 +2,650	+61%	+$283K	﹤0.01%	608
2019 Q2	$555K	Buy	4,355 +1,767	+68%	+$254K	﹤0.01%	593
2019 Q1	$467K	Buy	+2,588	New	+$374K	﹤0.01%	594

Other funds holding SRGA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DFPG Investments Sandy, Utah $1.28B AUM 27.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

TownSquare Capital Provo, Utah $444M AUM 24.03% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s SRGA Position: Q1 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q1 2021, closing a stake of 2,383 shares — an estimated $157K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SRGA in Q1 2019 and held it in 8 quarters. The position peaked at $838K in Q2 2020. 105 funds tracked by Wall St. Rank hold SRGA as of Q1 2021.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 2,383 Surgalign Holdings, Inc. Common Stock shares in Q1 2021, an estimated $157K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Surgalign Holdings, Inc. Common Stock in Q1 2019 and held it in 8 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Surgalign Holdings, Inc. Common Stock position peaked at $838K in Q2 2020.
105 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q1 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2021, filed 13 May 2021.